CFTR and cystic fibrosis: Overall, given the continued development of therapeutics to treat CF as well as the potential expansion of CFTR modulators to treat diseases other than CF, it may be valuable to determine the longevity of the impact of VX-770 on the function of the CFTR in the airway epithelium in vivo.